Fact CheckerSign in

NCT05672628Completed

The Feasibility, Usability, and Acceptability of Using the Oculus™ Virtual Reality Gaming Technology in Stroke Survivors for Upper Extremity and Cognitive Rehabilitation

Source: ClinicalTrials.gov · Last updated 17 Aug 2025

Brief summary (registry, in English)

The purpose of this study is to test the (a) feasibility, (b) usability, and (c) acceptability of using the Oculus Virtual Reality (VR) for chronic stroke survivors who have mild-moderate cognitive and unilateral arm impairment to administer upper extremity and cognitive rehabilitation, to calculate the change in upper extremity and cognition scores on standardized measurements per standard of care and to qualitatively explore the impact of engaging caregivers in supporting the stroke survivor's rehabilitation and the impact of this engagement on the stroke survivor and caregiver dyad using semi-structured interviews.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
20 Dec 2022
Start date
5 Mar 2023
Primary completion date
17 Jul 2024
Lead sponsor
The University of Texas Health Science Center, Houston
Diseases
Stroke
NCT number
NCT05672628

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 5 Mar 2023 to the primary completion date, 17 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • have a history of motion sickness/ vertigo/ dizziness/seizures, claustrophobia, blind/deaf, and cannot hold the controller in their affected arm.

Other

  • do not have score ranges that indicate mild to moderate severity on the Montreal Cognitive Assessment (MoCA )(15-25) or other appropriate cognitive screening test selected by the speech language pathologist
  • has aphasia, hemiopsia, and other neurological deficits that prevents the participant from being examined using MoCA or a modified MoCA, Fugl-Meyer Assessment - Upper Extremity (FM) (20-50)
  • unstable while standing unassisted

Who the study is looking for

  • Ischemic or hemorrhagic stroke diagnosis within 6 months to 2 years of enrollment
  • can read, write, comprehend, speak English
  • willing and able to provide informed consent
  • Caregivers must live in the home with the stroke survivor

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The University of Texas Health Science Center at Houston
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.